First Time Loading...

Evelo Biosciences Inc
NASDAQ:EVLO

Watchlist Manager
Evelo Biosciences Inc Logo
Evelo Biosciences Inc
NASDAQ:EVLO
Watchlist
Price: 0.001 USD Market Closed
Updated: Jun 3, 2024

Evelo Biosciences Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Evelo Biosciences Inc
Total Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Evelo Biosciences Inc
NASDAQ:EVLO
Total Liabilities
$47.3m
CAGR 3-Years
-5%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Liabilities
$140.9B
CAGR 3-Years
1%
CAGR 5-Years
17%
CAGR 10-Years
19%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities
$38.8B
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Total Liabilities
$88B
CAGR 3-Years
18%
CAGR 5-Years
11%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities
$5.4B
CAGR 3-Years
20%
CAGR 5-Years
24%
CAGR 10-Years
19%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities
$7.4B
CAGR 3-Years
8%
CAGR 5-Years
17%
CAGR 10-Years
22%

See Also

What is Evelo Biosciences Inc's Total Liabilities?
Total Liabilities
47.3m USD

Based on the financial report for Sep 30, 2023, Evelo Biosciences Inc's Total Liabilities amounts to 47.3m USD.

What is Evelo Biosciences Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
14%

Over the last year, the Total Liabilities growth was -39%. The average annual Total Liabilities growth rates for Evelo Biosciences Inc have been -5% over the past three years , 14% over the past five years .